Science Corporation’s vision-restoring chip wins EU approval

Hodak says bringing PRIMA to market is “the most important thing for the company, because we don’t get to do the bio hybrid stuff long term if you don’t have a great vision business. That’s what’s really financing the rest of it — that’s the thing that investors know how to build spreadsheets around.”